NCT00521989View on ClinicalTrials.gov

CRx-102 Osteoarthritis Multicenter Evaluation Trial

PHASE2TerminatedINTERVENTIONAL

Enrollment

279

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions

Knee Osteoarthritis

Interventions

DRUG

CRx-102 (2.7/90)

CRx-102 dose 1

DRUG

Prednisolone

Prednisolone

DRUG

Placebo

Placebo

DRUG

CRx-102 (2.7/180)

CRx-102 dose 2

DRUG

CRx-102 (2.7/360)

CRx-102 dose 3

Trial Locations (58)

Unknown

Huntsville

Chandler

Mesa

Phoenix

Tuscon

Little Rock

Anaheim

Rancho Mirage

Upland

Westlake Village

DeLand

Jupiter

Kissimee

Largo

Longwood

Palm Harbor

Sarasota

Tampa

Atlanta

Paducah

Covington

Towson

Brockton

Haverhill

Peabody

Worcester

Bingham Farms

Missoula

Reno

Haddon Heights

Voorhees Township

Albuquerque

New York

Plainview

Rochester

Hickory

High Point

Winston-Salem

Fargo

Cincinnati

Dayton

Mayfield Village

Oklahoma City

Eugene

Duncansville

Pittsburgh

West Reading

Cumberland

Warwick

Dallas

Houston

San Antonio

Bountiful

Sandy City

Roanoke

Virginia Beach

Tacoma

Kitchener

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Zalicus

INDUSTRY

NCT00521989 - CRx-102 Osteoarthritis Multicenter Evaluation Trial | Biotech Hunter | Biotech Hunter